The pro-inflammatory triggers apparently drove up TNF- and IL-6 release, whereas GHK-Cu apparently pulled both cytokines down
BPC-157 is not automatically better than TB-500, and TB-500 is not automatically better than BPC-157
The distinction has to be real and documented
Tabata et al., 1999) are illustrative for the pertinence of the poorly resolved problem, illustrative for the diversity of the carriers (i.e., hyaluronate gel carrier (Wang and Aspengberg, 1996), alginate/heparinsacharose microspheres and films (Yu et al., 1998), cellulose gel (Thorn and Aspenberg, 1993), defective form of Pseudomonas exotoxin (Siegall et al., 1994), fibrin adhesive carrier (Walter et al., 1996), biodegredable hydrogen gelatin (Tabata et al., 1999), natural coral, and collagen (Sikiric et al., 2018), there is an inescapable diversity of the carriers and thereby, an evident diversity of the obtained beneficial effects, and disable conclusion
Research on 5-Amino-1MQ is still emerging, but preclinical studies suggest it has a good safety profile when used properly